India to Philippines: Serum Export Trade Route

The India to Philippines Serum corridor is one of India's established pharmaceutical export routes, with 89 shipments documented worth a combined $7.5M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's serum manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $83.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with serum's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 20.2%, placing it at rank #19 among India's top serum export destinations globally.

On the import side, key buyers of Indian serum in Philippines include CUST ID: BILTP, BSV BIOSCIENCE PHILS. INC , BSV BIOSCIENCE PHILIPPHINES INC and 25 others. CUST ID: BILTP is the single largest importer with 8 shipments valued at $1.5M USD.

India's serum exports to Philippines are driven primarily by a handful of large-scale manufacturers. BHARAT SERUMS AND VACCINES LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, VINS BIOPRODUCTS LIMITED, BHARAT SERUMS AND VACCINES LIMITED — together account for 95% of total trade value on this route. The average shipment value of $83.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as equirab 1000iu/5ml [rabies antiserum - equine] and rabies antiserum (vinrab 1000 iu) (128 vails free of cost)vls, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CUST ID: BILTP is the largest importer with 8 shipments worth $1.5M USD — representing 20% of all serum imports from India on this route. A total of 28 buyers are active on this corridor.